Clinical Psilocybin Therapy for Addiction

Clinical Psilocybin Therapy for Addiction

Clinical Psilocybin Therapy for Addiction with Dr. Albert Garcia-Romeu

Today’s show features our first guest from Johns Hopkins University, Dr. Albert Garcia-Romeu. We discuss the history of clinical research on psilocybin, its implications, and its bright future for healing. We also discuss the possibility of treating Alzheimer’s and dementia with psilocybin. Dr. Garcia-Romeu gives us an in-depth perspective on the execution of this important research, and hopefully inspires others to fuel its progression.

.

Dr. Albert Garcia-Romeu is a member of the Psychiatry and Behavioral Sciences faculty at the Johns Hopkins University and a Guest Researcher at the National Institute on Drug Abuse Intramural Research Program. His research examines the effects of psychedelics in humans, with a focus on psilocybin as an aid in the treatment of addiction. He received his doctorate in Psychology in 2012 from the Institute of Transpersonal Psychology in Palo Alto, CA, where he studied self-transcendence and meditation, and their relationship to mental health. His current research interests include clinical applications of psychedelics, mindfulness, and altered states of consciousness and their underlying psychological mechanisms. He additionally studies real-world drug use patterns and impacts on public health, and the role of spirituality in mental health and addiction.






 

Alex Dorr

Alex Dorr is the founder and CEO of Mushroom Revival. He launched Mushroom Revival with a mission to revive health with the power of mushrooms.

Other posts that might interest you